BenzingaDoubao · 实盘不做把握 7/10不做原因:已被定价
北京时间·🕒 发布 22:05:09·⟳ 抓取 22:05:21 +12s·⚡ 决策 10-19 22:06:43 +1m22s·7.8 天前
Benzinga周一涨幅榜：Silence Therapeutics被默克(Merck KGaA)以每股ADS 20美元现金收购股价暴涨126%，其余为已各自因利好跳空的热门股汇总
这是一篇盘中涨幅榜聚合稿，唯一有实质内容的SLN收购为现金固定对价、股价当日已涨125.7%至19.575，距20美元对价仅约2.2%价差，属低收益、需等待交割并承担审批/破裂风险的并购套利，短窗口无正期望edge；IRON/MANE等已因各自临床利好当日大幅跳空，本文仅二手罗列、无新增事实，其余成分股更无任何催化。
📄 原文Benzinga↗ 原文
Silence Therapeutics, Disc Medicine, Veradermics And Other Big Stocks Moving Higher On Monday
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Monday. Shares of Silence Therapeutics PL…
不做 Silence Therapeutics（SLN.US）
现金收购对价固定20美元/ADS，当日已涨125.7%至19.575，剩余仅约2.2%并购套利价差，需等待交割并承担监管/股东审批与交易破裂风险，短窗口无正期望edge；其余IRON/MANE等为当日已跳空个股的二手涨幅罗列，无新增催化。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
SLN被默克20美元/ADS现金收购，现价19.575已基本完成重定价，仅剩约2.2%套利空间且附交割与时间风险；其余均为当日已跳空个股的二手涨幅汇总，无新鲜可交易edge，故不做。
🔎 新鲜度:最早出现 2026-10-19 · 扩散 high · price-in 风险 high ↗
关键理由
- SLN现金对价20美元锁定上方，现价19.575使做多仅余约2.2%价差，无法补偿交易与破裂风险
- 本文为movers聚合稿，IRON/MANE等的实质利好已在当日分别+24.7%/+5.7%反映，无本次新增催化
主要风险
- SLN若出现竞购加价，固定对价套利逻辑改变，但当前无此信息且不在短窗口edge内
- 并购若因监管/融资/股东批准失败，SLN可能跌回个位数，做多套利面临本金损失
反向证据
- 做多前查反向 · 来源 web · 影响 weakens
现金固定对价20美元已基本被现价19.575计入，做多仅余约2.2%价差，却需承担竞购落空/审批/融资等破裂回撤风险，风险收益不对称
检索:Silence Therapeutics Merck KGaA acquisition competing bidder regulatory antitrust risk deal break
先例如何影响了这次决策
对本次决策的影响:确认SLN不做：上方被现金对价封顶、价差太薄且附破裂风险；其余为二手涨幅罗列，无新鲜催化，整体AVOID。
方向:现金收购要约价固定时，标的价格在公告后迅速向对价收敛，剩余价差为并购套利、由完成概率与时间价值定价，不构成方向性事件交易。
涨幅量级:无可用的高相似对齐先例；本次以SLN现价19.575相对20美元固定对价的实际价差(约2.2%)直接判定幅度不足，无需先例校准tp/sl。
形态:并购标的公告日跳空至对价附近后，短窗口通常无额外方向性涨幅，仅留窄幅套利价差；属结构性见顶而非需要统计验证的模式。
工具执行结果 · 成功 2 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 11 ms
{"result": "search_processed_events:agent query=`disc medicine bitopertin apollo phase 3 topline | silence therapeutics merck kgaa acquisition $20 per ads | sln merck kgaa buyout $1.1 billion enterprise value | veradermics vdphl0`；结构化索引覆盖完整 6 小时；旧记录兼容扫描近 0.0/6 小时、0 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent - stock_quote 成功 stock_tools HTTP · 44 ms
{
原文全文
展开原文 · 2,174 字
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Monday.
Shares of Silence Therapeutics PLC – ADR (NASDAQ:SLN) rose sharply after the company agreed to be acquired by Merck KGaA, Darmstadt, Germany.
The purchase price of $20 per ADS in cash represents an enterprise value of $1.1 billion and an equity value of around $1.3 billion.
Silence Therapeutics shares jumped 125.7% to $19.60 on Monday.
Here are some other big stocks recording gains in today’s session.
- Disc Medicine Inc (NASDAQ:IRON) gained 24.7% to $70.90 after the company announced topline results from the APOLLO Phase 3 trial of bitopertin in erythropoietic protoporphyria, including X-linked protoporphyria met all its primary and secondary endpoints.
- Applied Digital Corp (NASDAQ:APLD) surged 9.6% to $19.78.
- AXT Inc (NASDAQ:AXTI) rose 9.4% to $56.33.
- Parabilis Medicines Inc (NASDAQ:PBLS) gained 9.3% to $24.86. Parabilis Medicines will present updated clinical data for Zolucatetide in patients with desmoid tumors at ESMO Congress 2026.
- United States Antimony Corp (NYSE:UAMY) rose 9.1% to $3.10.
- SanDisk Corp (NASDAQ:SNDK) rose 7.8% to $1,401.54.
- Maxlinear Inc (NASDAQ:MXL) gained 7.7% to $76.82.
- FormFactor Inc (NASDAQ:FORM) rose 6.6% to $111.91.
- Western Digital Corp (NASDAQ:WDC) climbed 5.9% to $351.60.
- Veradermics Inc (NYSE:MANE) gained 5.7% to $115.00 as the company’s oral VDPHL01 achieved early, consistent, and robust hair growth in positive Phase 3 ‘304’ clinical trial in male pattern hair loss.
- AST SpaceMobile Inc (NASDAQ:ASTS) rose 5.5% to $42.88.
- Intel Corp (NASDAQ:INTC) gained 4.8% to $94.23. JP Morgan analyst Harlan Sur upgraded Intel from Underweight to Neutral and maintained the price target of $85.
- Rambus Inc (NASDAQ:RMBS) rose 4.7% to $91.35.
- Alpha and Omega Semiconductor Ltd (NASDAQ:AOSL) climbed 4.4% to $22.70. Alpha and Omega Semiconductor will announce fiscal first quarter financial results on Nov. 5.
- Aehr Test Systems (NASDAQ:AEHR) gained 4.2% to $63.16.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
Shares of Silence Therapeutics PLC – ADR (NASDAQ:SLN) rose sharply after the company agreed to be acquired by Merck KGaA, Darmstadt, Germany.
The purchase price of $20 per ADS in cash represents an enterprise value of $1.1 billion and an equity value of around $1.3 billion.
Silence Therapeutics shares jumped 125.7% to $19.60 on Monday.
Here are some other big stocks recording gains in today’s session.
- Disc Medicine Inc (NASDAQ:IRON) gained 24.7% to $70.90 after the company announced topline results from the APOLLO Phase 3 trial of bitopertin in erythropoietic protoporphyria, including X-linked protoporphyria met all its primary and secondary endpoints.
- Applied Digital Corp (NASDAQ:APLD) surged 9.6% to $19.78.
- AXT Inc (NASDAQ:AXTI) rose 9.4% to $56.33.
- Parabilis Medicines Inc (NASDAQ:PBLS) gained 9.3% to $24.86. Parabilis Medicines will present updated clinical data for Zolucatetide in patients with desmoid tumors at ESMO Congress 2026.
- United States Antimony Corp (NYSE:UAMY) rose 9.1% to $3.10.
- SanDisk Corp (NASDAQ:SNDK) rose 7.8% to $1,401.54.
- Maxlinear Inc (NASDAQ:MXL) gained 7.7% to $76.82.
- FormFactor Inc (NASDAQ:FORM) rose 6.6% to $111.91.
- Western Digital Corp (NASDAQ:WDC) climbed 5.9% to $351.60.
- Veradermics Inc (NYSE:MANE) gained 5.7% to $115.00 as the company’s oral VDPHL01 achieved early, consistent, and robust hair growth in positive Phase 3 ‘304’ clinical trial in male pattern hair loss.
- AST SpaceMobile Inc (NASDAQ:ASTS) rose 5.5% to $42.88.
- Intel Corp (NASDAQ:INTC) gained 4.8% to $94.23. JP Morgan analyst Harlan Sur upgraded Intel from Underweight to Neutral and maintained the price target of $85.
- Rambus Inc (NASDAQ:RMBS) rose 4.7% to $91.35.
- Alpha and Omega Semiconductor Ltd (NASDAQ:AOSL) climbed 4.4% to $22.70. Alpha and Omega Semiconductor will announce fiscal first quarter financial results on Nov. 5.
- Aehr Test Systems (NASDAQ:AEHR) gained 4.2% to $63.16.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
ab7f790b70· 2026-10-19 22:06 · doubao / doubao-seed-evolving-latest-version · 策略包658c0c1e2ba5当前